E. Cherry et al., CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PARTICLES THAT EXPRESS PROTEASE-REVERSE TRANSCRIPTASE FUSION PROTEINS, Journal of Molecular Biology, 284(1), 1998, pp. 43-56
We have selectively mutagenized specific residues at the junction betw
een the protease (PR) and reverse transcriptase (RT) genes of human im
munodeficiency virus type 1 (HIV-1) to study the effects of PR-RT fusi
on proteins in the context of a full-length, infectious proviral con s
truct. Mutant viruses derived from COS-7 cells transfected with this c
on struct were analyzed in regard to each of viral replication, matura
tion; and infectivity. Immunoblot analysis revealed that the mutation
prevented cleavage between the PR and RT proteins and that both existe
d as a PR-RT fusion protein in each of cellular and viral lysates. Int
erestingly, intracellular PR that existed within the PR-RT fusion prot
ein remained functionally active, whereby HIV-1 precursor proteins wer
e processed efficiently. Furthermore, the RT component of the fusion p
rotein also retained its enzymatic activity as shown in RT assays. Ele
ctron microscopy revealed that the mutant viruses containing the PR-RT
fusion protein possessed wild-type morphology. These viruses also dis
played wild-type sensitivities to inhibitors of each of the HIV-1 PR a
nd RT activities. However, viruses containing the PR-RT fusion protein
were 20 times less infectious than wild-type viruses. This defect was
further pronounced when mutated Gag-Pol proteins were overexpressed a
s a consequence of an additional mutation that interfered with framesh
ifting. Thus, unlike cleavage site mutations at the N terminus of PR,
a cleavage site mutation between PR and RT did not affect the enzymati
c activities of either PR or RT and viruses containing PR-RT fusion pr
oteins were viable. (C) 1998 Academic Press.